(Jeenah Moon / Getty)
(YUMA, AZ) With the Biden administration moving up the date when Americans will be eligible for the COVID-19 vaccine, the rollout is moving ahead, including in Yuma, where several locations have it on hand, according to an online database.
On April 3, the Biden administration moved up its timeline for eligibility, in an attempt to clear up confusion generated by state rollout plans: All Americans are eligible for the vaccine as of April 19.
“That doesn’t mean they will get it that day, it means they can join the line,” said White House Press Secretary Jen Psaki.
Here are several locations where you can find the vaccine in Yuma:
Phone: (928) 726-9163
Available vaccine types: Moderna
Walk-ins accepted
Hours: Monday: 8:00 am - 5:00 pm; Tuesday: 8:00 am - 5:00 pm; Wednesday: 8:00 am - 5:00 pm
Phone: (928) 342-3433
Available vaccine types: Pfizer-BioNTech (age 12+)
Hours: Monday: 09:00am-08:00pm; Tuesday: 09:00am-08:00pm; Wednesday: 09:00am-08:00pm
Phone: (928) 343-7466
Available vaccine types: Johnson & Johnson/Janssen (age 18+)
Hours: Monday: 10:00am-06:00pm; Tuesday: 10:00am-06:00pm; Wednesday: 10:00am-06:00pm
Appointment Available as of 2021-09-23 20:52:06 PDT
Phone: (928) 782-2529
Available vaccine types: Moderna (age 18+), Johnson & Johnson/Janssen (age 18+)
Hours: Monday: 10:00 am - 9:00 pm; Tuesday: 10:00 am - 9:00 pm; Wednesday: 10:00 am - 9:00 pm
Appointment Available as of 2021-09-23 20:52:06 PDT
Phone: (928) 342-1332
Available vaccine types: Moderna (age 18+), Johnson & Johnson/Janssen (age 18+)
Hours: Monday: 10:00 am - 9:00 pm; Tuesday: 10:00 am - 9:00 pm; Wednesday: 10:00 am - 9:00 pm
Phone: 928-343-2311
Available vaccine types: Moderna (age 18+), Pfizer-BioNTech (age 12+), Johnson & Johnson/Janssen (age 18+)
Walk-ins accepted
Hours: Monday: 08:00am - 08:00pm; Tuesday: 08:00am - 08:00pm; Wednesday: 08:00am - 08:00pm
Phone: 928-783-3684
Available vaccine types: Moderna (age 18+), Johnson & Johnson/Janssen (age 18+)
Walk-ins accepted
Hours: Monday: 9:00 am - 1:30pm, 2:00 pm - 7:00 pm; Tuesday: 9:00 am - 1:30pm, 2:00 pm - 7:00 pm; Wednesday: 9:00 am - 1:30pm, 2:00 pm - 7:00 pm
Phone: 928-342-1034
Available vaccine types: Moderna (age 18+), Pfizer-BioNTech (age 12+)
Walk-ins accepted
Hours: Monday: 08:00am - 08:00pm; Tuesday: 08:00am - 08:00pm; Wednesday: 08:00am - 08:00pm
Phone: 928-344-0453
Available vaccine types: Moderna (age 18+), Pfizer-BioNTech (age 12+)
Walk-ins accepted
Hours: Monday: 08:00am - 10:00pm; Tuesday: 08:00am - 10:00pm; Wednesday: 08:00am - 10:00pm
Phone: 928-783-6834
Available vaccine types: Moderna (age 18+), Pfizer-BioNTech (age 12+)
Walk-ins accepted
Hours: Monday: 09:00am - 07:00pm; Tuesday: 09:00am - 07:00pm; Wednesday: 09:00am - 07:00pm
Phone: 928-341-0589
Available vaccine types: Moderna (age 18+), Pfizer-BioNTech (age 12+)
Walk-ins accepted
Hours: Monday: 09:00am - 09:00pm; Tuesday: 09:00am - 09:00pm; Wednesday: 09:00am - 09:00pm
Phone: 928-344-0992
Available vaccine types: Moderna (age 18+), Johnson & Johnson/Janssen (age 18+)
Walk-ins accepted
Hours: Monday: 9:00 am - 7:00 pm; Tuesday: 6:00 am - 7:00 pm; Wednesday: 9:00 am - 7:00 pm
Phone: 928-344-5974
Available vaccine types: Moderna (age 18+)
Walk-ins accepted
Hours: Monday: 9:00 am - 7:00 pm; Tuesday: 6:00 am - 7:00 pm; Wednesday: 9:00 am - 7:00 pm
Phone: 928-317-2776
Available vaccine types: Moderna (age 18+), Johnson & Johnson/Janssen (age 18+)
Walk-ins accepted
Hours: Monday: 9:00 am - 12:00 pm, 12:30pm - 7:00 pm; Tuesday: 6:00 am - 12:00 pm, 12:30pm - 7:00 pm; Wednesday: 9:00 am - 12:00 pm, 12:30pm - 7:00 pm
Phone: 928-261-4120
Available vaccine types: Moderna (age 18+)
Walk-ins accepted
Hours: Monday: 9:00 am - 1:30pm, 2:00 pm - 7:00 pm; Tuesday: 6:00 am - 1:30pm, 2:00 pm - 7:00 pm; Wednesday: 9:00 am - 1:30pm, 2:00 pm - 7:00 pm
(Location and vaccine availability data from VaccineFinder.org)
Note: On April 13 the U.S. Centers for Disease Control and Prevention announced a “pause” in administering the Johnson & Johnson vaccine while a panel reviews six cases where recipients of the vaccine developed a severe type of blood clot. Out of 6.8 million doses administered, cases in which patients developed clots are “extremely rare” the agency said in its statement, adding that part of the pause is to allow time to distribute information to doctors about the potential for the side effects.